![](https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2019/5/3d_illustration_Cells%2c_Cancer_Cells_or_Lymphocytes_-_Illustration_-_Design_Cells_A1_7f1fe90259144c2e9a161d08617f8ace-620x480.jpg)
FDA approval of lifileucel: A milestone in tumor-infiltrating lymphocyte therapy for advanced melanoma
The recent U.S. Food and Drug Administration approval of lifileucel, the first commercial tumor-infiltrating lymphocyte (TIL) therapy for advanced melanoma, marks a significant breakthrough in cancer therapy. In a new commentary published in Cancer Cell, …